SCHEMBL5685665

SCHEMBL5685665

COc1cc(/C=C(\C)C(=O)O)ccc1OCc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 7/20 0.62
HPGD P15428 5/20 0.58
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 3/20 0.58
HTT P42858 1/20 0.58
SMN1; SMN2 Q16637 3/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
HDAC3 O15379 1/20 0.54
HDAC4 P56524 1/20 0.54
HDAC1 Q13547 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC2 Q92769 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
HDAC8 Q9BY41 1/20 0.54
HDAC6 Q9UBN7 1/20 0.54
HDAC9 Q9UKV0 1/20 0.54
HDAC5 Q9UQL6 1/20 0.54
PTGER4 P35408 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5685669 1.00 APP (0.62) APPHPGDALDH1A1KDM4EHTT
SCHEMBL5362058 0.95 ALDH1A1 (0.58) APPHPGDALDH1A1KDM4EHTT
SCHEMBL7356814 0.95 ALDH1A1 (0.58) APPHPGDALDH1A1KDM4EHTT
SCHEMBL5362060 0.95 ALDH1A1 (0.58) APPHPGDALDH1A1KDM4EHTT
SCHEMBL22555963 0.89 APP (0.61) APPHPGDALDH1A1KDM4EHTT
SCHEMBL13755051 0.88 APP (0.63) APPHPGDALDH1A1KDM4EHTT
SCHEMBL5350808 0.87 ALDH1A1 (0.58) APPHPGDALDH1A1KDM4EHTT
SCHEMBL5350800 0.87 ALDH1A1 (0.58) APPHPGDALDH1A1KDM4EHTT
SCHEMBL7354893 0.87 ALDH1A1 (0.58) APPHPGDALDH1A1KDM4EHTT
SCHEMBL14198065 0.87 HPGD (0.61) APPHPGDALDH1A1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060122064-A1 Amides and method for plant diseases control with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-06-08 US disclosed
US-20060122065-A1 Amide compound and method of controlling plant disease with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-06-08 US disclosed
EP-1640360-A1 AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-29 EP disclosed
EP-1577290-A1 AMIDE COMPOUND AND METHOD OF CONTROLLING PLANT DISEASE WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2005-09-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122065-A1 Amide compound and method of controlling plant disease with the same CBR3, C5, CLN6 APP 3437/4885HPGD 3908/4885ALDH1A1 3850/4885
US-20060122064-A1 Amides and method for plant diseases control with the same ARG1, ARGLU1, ARG2 APP 3090/4885HPGD 3826/4885ALDH1A1 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.